O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-3.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.82B
AUM Growth
+$4.82B
(-12%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
44.7%
Holding
132
New
19
Increased
23
Reduced
22
Closed
17
Top Buys
| 1 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
$93.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
$86.8M |
| 3 |
Edwards Lifesciences
EW
|
$84.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$38.9M |
| 5 |
Cytokinetics
CYTK
|
$38.4M |
Top Sells
| 1 |
Amgen
AMGN
|
$81.3M |
| 2 |
Elevance Health
ELV
|
$55.2M |
| 3 |
Merck
MRK
|
$48.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$47.5M |
| 5 |
Evolent Health
EVH
|
$47.1M |
Sector Composition
| 1 | Healthcare | 98.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Insmed
INSM
$28.8B
| $6.53M | 0.13% | +94,559 | New | +$6.53M |
|
77
enGene Holdings
ENGN
$236M
| $6.12M | 0.13% | +920,339 | New | +$6.12M |
|
|
IMA
78
ImageneBio, Inc. Common Stock
IMA
$150M
| $5.8M | 0.12% | 3,539,358 | – | – |
|
79
InspireMD
NSPR
$102M
| $5.61M | 0.12% | 2,133,405 | – | – |
|
80
Traws Pharma
TRAW
$9.89M
| $5.38M | 0.11% | 605,531 | – | – |
|
|
BIOA
81
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $5.34M | 0.11% | 921,959 -501,511 | -35% | -$2.9M |
|
82
X4 Pharmaceuticals
XFOR
$84.2M
| $5.23M | 0.11% | 7,133,515 | – | – |
|
|
BCAX
83
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $5.2M | 0.11% | 298,301 +26,391 | +10% | +$460K |
|
84
Milestone Pharmaceuticals
MIST
$156M
| $4.72M | 0.1% | 2,000,000 | – | – |
|
85
Repare Therapeutics
RPTX
$71.7M
| $4.35M | 0.09% | 3,322,488 | – | – |
|
86
Passage Bio
PASG
$22.7M
| $4.2M | 0.09% | 7,404,869 -2,418,007 | -25% | -$1.37M |
|
87
Krystal Biotech
KRYS
$4.27B
| $3.68M | 0.08% | 23,500 | – | – |
|
|
ARDT
88
Ardent Health, Inc.
ARDT
$1.82B
| $3.52M | 0.07% | 206,000 | – | – |
|
|
CMMB
89
Chemomab Therapeutics
CMMB
$16.3M
| $3.15M | 0.06% | 1,741,273 | – | – |
|
|
CBLL
90
CeriBell, Inc. Common Stock
CBLL
$434M
| $2.91M | 0.06% | +112,500 | New | +$2.91M |
|
91
Fate Therapeutics
FATE
$120M
| $2.77M | 0.06% | 1,680,580 | – | – |
|
92
PepGen
PEPG
$38M
| $2.47M | 0.05% | 653,016 -144,342 | -18% | -$547K |
|
93
Instil Bio
TIL
$182M
| $2.23M | 0.05% | 116,785 +83,085 | +247% | +$1.59M |
|
94
Nkarta
NKTX
$151M
| $2.05M | 0.04% | 821,400 -659,200 | -45% | -$1.64M |
|
95
Lyell Immunopharma
LYEL
$213M
| $1.99M | 0.04% | 3,103,623 -2,982,378 | -49% | -$1.91M |
|
96
Immunovant
IMVT
$2.56B
| $1.94M | 0.04% | +78,500 | New | +$1.94M |
|
97
Akero Therapeutics
AKRO
$3.74B
| $1.84M | 0.04% | +66,000 | New | +$1.84M |
|
98
Tango Therapeutics
TNGX
$747M
| $1.7M | 0.04% | +550,000 | New | +$1.7M |
|
|
TSBX
99
DELISTED
Turnstone Biologics
TSBX
| $1.54M | 0.03% | 3,099,265 | – | – |
|
100
Amylyx Pharmaceuticals
AMLX
$836M
| $1.32M | 0.03% | +348,000 | New | +$1.32M |
|